Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort.
Michael G SensionLaurence BrunetRicky K HsuJennifer S FuscoQuateka CochranChristine UranakaGayathri SridharVani VannappagariJean Van WykLewis McCurdyMichael B WohlfeilerGregory P FuscoPublished in: Infectious diseases and therapy (2023)
In this large US cohort, most monthly CAB + RPV LA injections were administered on time and high levels of virologic control were achieved. These results suggest that CAB + RPB LA injectable can be administered effectively during routine clinical care.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv infected patients
- hiv positive
- platelet rich plasma
- human immunodeficiency virus
- ultrasound guided
- healthcare
- palliative care
- hepatitis c virus
- hiv aids
- hiv testing
- electronic health record
- quality improvement
- clinical practice
- big data
- pain management
- machine learning
- south africa
- deep learning
- smoking cessation